| 1 |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021，71(1): 7-33.
|
| 2 |
Lyons YA, Reyes HD, McDonald ME, et al. Interval debulking surgery is not worth the wait: a national cancer database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy[J]. Int J Gynecol Cancer, 2020, 30(6): 845-852.
|
| 3 |
Yao SE, Tripcony L, Sanday K, et al. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2020, 30(12): 1935-1942.
|
| 4 |
Reich H, McGlynn F, Wilkie W. Laparoscopic management of stage i ovarian cancer. a case report[J]. J Reprod Med, 1990, 35(6): 601-605.
|
| 5 |
Armstrong DK, Alvarez RD, Bakkum-Gamez JN, et al. Ovarian cancer, version 2.2020, nccn clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021, 19(2): 191-226.
|
| 6 |
Gueli Alletti S, Capozzi VA, Rosati A, et al. Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature[J]. Minerva Med, 2019, 110(4): 341-357.
|
| 7 |
王刚，陈扬平. 晚期卵巢癌腹腔镜下肿瘤细胞减灭术的临床相关问题[J/CD]. 中华妇幼临床医学杂志(电子版), 2016, 12(4): 373-378.
|
| 8 |
王玲，张国楠. 腹腔镜手术在晚期卵巢癌中的应用现状与争议[J]. 实用妇产科杂志，2013, 29(1): 18-21.
|
| 9 |
Dai L, Song K, Di W. Adipocytes: active facilitators in epithelial ovarian cancer progression[J]. J Ovarian Res, 2020, 13(1): 1-13.
|
| 10 |
文仲勇，王帅，林静霞，等. 卵巢癌腹腔镜下大网膜切除术的改良[J]. 中国微创外科杂志，2020, 26(6): 512-514，519.
|
| 11 |
Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer[J]. N Engl J Med, 2018, 379(20): 1895-1904.
|
| 12 |
Melamed A, Margul DJ, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer[J]. N Engl J Med, 2018, 379(20): 1905-1914.
|
| 13 |
Amara DP, Nezhat C, Teng NN, et al. Operative laparoscopy in the management of ovarian cancer[J]. Surg Laparosc Endosc, 1996, 6(1): 38-45.
|
| 14 |
Nezhat FR, Finger TN, Vetere P, et al. Comparison of perioperative outcomes and complication rates between conventional versus robotic-assisted laparoscopy in the evaluation and management of early, advanced, and recurrent stage ovarian, fallopian tube, and primary peritoneal cancer[J]. Int J Gynecol Cancer, 2014, 24(3): 600-607.
|
| 15 |
Abitbol J, Gotlieb W, Zeng Z, et al. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy[J]. Int J Gynecol Cancer, 2019, 29(9): 1341-1347.
|
| 16 |
Fanning J, Yacoub E, Hojat R. Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: success, morbidity and survival[J]. Gynecol Oncol, 2011, 123(1): 47-49.
|
| 17 |
Gu B, Xia L, Ge H, et al. Preoperative PET/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study[J]. Quant Imaging Med Surg, 2020, 10(3): 743-753.
|
| 18 |
Shi T, Zhu J, Feng Y, et al. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial[J]. Lancet Oncol, 2021, 22(4): 439-449.
|
| 19 |
Fagotti A, Ferrandina G, Fanfani F, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study[J]. Ann Surg Oncol, 2006, 13(8): 1156-1161.
|
| 20 |
Fagotti A, Ferrandina G, Fanfani F, et al. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma[J]. Am J Obstet Gynecol, 2008, 199(6): 1-6.
|
| 21 |
Fagotti A, Vizzielli G, De Iaco P, et al. A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer[J]. Am J Obstet Gynecol, 2013, 209(5): 1-11.
|
| 22 |
Fagotti A, Vizzielli G, Fanfani F, et al. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience[J]. Gynecol Oncol, 2013, 131(2): 341-346.
|